DOW vs TRDA · P/E 74, rev $42.96B vs P/E 12, rev $210.8M
Dow Inc (DOW) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the DOW and TRDA stock pages for the full models.
Not investment advice.